Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to ...

A New Jersey pharmaceutical company is recalling more than 230,000 bottles of duloxetine antidepressants after detecting a ...

It's the generic for one of the most-prescribed drugs treating America's 21 million individuals managing depression. Here's ...

You can't beat Dow Jones stocks for stability and defense in a down market. By the same token, the blue chip average won't always keep up in a rising market. The current state of concentrated ...

An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...

The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...